High-grade Serous Ovarian Carcinoma (HGSOC) Clinical Trials

12 clinical trials for High-grade Serous Ovarian Carcinoma (HGSOC) across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors. — RECRUITING · PHASE1
• First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer — RECRUITING · PHASE1
• A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors — RECRUITING · PHASE1
• OV Precision: Study Examining the Benefit of a Tumor- and Patient-specific Cancer Therapy — RECRUITING · NA
• MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO) — RECRUITING · PHASE3
• Artificial Intelligence-guided Precision Treatment of High-grade Serous Ovarian Carcinoma — NOT_YET_RECRUITING
• Prognostic Value of KELIM Score and Inflammatory Markers in Ovarian Cancer — ACTIVE_NOT_RECRUITING
• Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications — TERMINATED · PHASE1
• A Translational Study to Explore and Overcome Metabolic-driven Resistance Mechanisms to Standard Chemotherapy in High-grade Ovarian Cancer — NOT_YET_RECRUITING
• Pembrolizumab With Chemotherapy and MK-4830 for Treating Participants With Ovarian Cancer (MK-4830-002) — COMPLETED · PHASE2
• Chromosomal Instability in Ovarian Cancer — OTHER
• A Study of LY3435151 in Participants With Solid Tumors — TERMINATED · PHASE1

Refine this search